Translational research

38P - Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells

Authors
  • Y. Liu (Munich, Germany)
  • R. Kiefl (Munich, Germany)
  • R. Huber (Munich, Germany)
  • A. Tufman (Munich, Germany)
  • D. Kauffmann-Guerrero (Munich, Germany)
Speakers
  • Y. Liu (Munich, Germany)

Previous ePoster
36P - Can a BALF profile distinguish hot vs cold lung tumors?

Next ePosters
41P - Diagnostic accuracy of droplet digital PCR (ddPCR) and amplification refractory mutation system PCR (ARMS-PCR) for detecting EGFR mutation in cell-free DNA of advanced lung cancer: A meta-analysis
44P - Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative
45P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative
46P - Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative
47P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative
48P - Education and lung cancer: A Mendelian randomisation study
49P - A Mendelian randomization study of the effects of Crohn’s disease on lung cancer
52P - Concordance, decision impact, and satisfaction for a computerized clinical decision support system in treatment of lung cancer patients
53P - Pulmonary tuberculosis: A hurdle to overcome for early lung cancer diagnosis in TB burden countries
57P - Non-small cell lung carcinoma (NSCLC) patients with baseline brain imaging: A prospective observational study